Codiak BioSciences Inc (CDAK) Stock
CDAK is no longer traded. Codiak BioSciences Inc was delisted from the Nasdaq in June 2023.
Prices on this page are historical; the last trade was June 6, 2023 at $0.01.
Codiak BioSciences Inc stock price history
CDAK final trading statistics
- Final close
- $0.01
- Final trading day
- Jun 6, 2023
- Market cap at delisting
- $2.83M
- Shares outstanding
- 36.83M
- Final 52-week range
- $0.01 – $4.25
- Avg. volume (final 3 mo.)
- 1,617,125
- All-time high (split-adj.)
- $32.30 · Dec 2020
- All-time low (split-adj.)
- $0.01 · May 2023
- Return since IPO
- -99.9%
- Beta
- 3.94
- Book value / share
- $1.06
- Price / book
- 0.01
Codiak BioSciences Inc annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $22.93M | -$3.9M | -$3.21 |
| FY2020 | $2.92M | -$86.1M | -$20.51 |
| FY2019 | $388.0K | -$75.8M | — |
| FY2018 | $0.00 | -$44.5M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Codiak BioSciences Inc
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. On March 27, 2023, Codiak BioSciences, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Codiak BioSciences Inc stock FAQ
What happened to Codiak BioSciences Inc stock?
Codiak BioSciences Inc stock was delisted from the Nasdaq. Its final close was $0.01 on June 6, 2023.
Is CDAK stock still trading?
No. CDAK was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.
What was the last price of CDAK stock?
CDAK closed at $0.01 on its final trading day, June 6, 2023, for a market value of about $2.83M.
What were Codiak BioSciences Inc's revenue and earnings in its last full fiscal year?
Codiak BioSciences Inc reported revenue of $22.93M and net income of -$3.9M in fiscal 2021, its last full year as a public company.
When did Codiak BioSciences Inc go public?
Codiak BioSciences Inc stock began trading on October 14, 2020.